Loading research dashboard…
Loading filter…
Cannabidivarin (CBDV) was first isolated and described by L. Vollner et al., 1969.
Cannabidivarinic acid (CBDVA) is the acidic precursor to CBDV.
CBDV belongs to the CBD family of phytocannabinoids and shares several characteristics, such as non-psychoactivity (i.e., no cognitive changes are associated).
CBDV occurs naturally in cannabis and has been gaining attention in the research community for its novel and potentially diverse therapeutic abilities.
Typically higher contents of CBDV are found in strains abundant in CBD.
Cannabidivarol, CBDV, CBD-V and other supplier-based synonyms.
IUPAC Name: 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol
Molecular Formula: C19H26O2
Source–PubChem
Only Members can view Properties and Effects information. See DEMO page.
Only Members can view Receptor Binding information. See DEMO page.
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.